Detalles de la búsqueda
1.
Quantitative, fluorescence-based in-situ assessment of protein expression.
Methods Mol Biol
; 520: 163-75, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19381954
2.
High HSP90 expression is associated with decreased survival in breast cancer.
Cancer Res
; 67(7): 2932-7, 2007 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17409397
3.
Expression patterns and prognostic value of Bag-1 and Bcl-2 in breast cancer.
Breast Cancer Res
; 10(2): R35, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18430249
4.
Nuclear to non-nuclear Pmel17/gp100 expression (HMB45 staining) as a discriminator between benign and malignant melanocytic lesions.
Mod Pathol
; 21(9): 1121-9, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18552823
5.
Standardization of estrogen receptor measurement in breast cancer suggests false-negative results are a function of threshold intensity rather than percentage of positive cells.
J Clin Oncol
; 29(22): 2978-84, 2011 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21709197
6.
Quantitative multiplexed analysis of ErbB family coexpression for primary breast cancer prognosis in a large retrospective cohort.
Cancer
; 115(11): 2400-9, 2009 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19330842
7.
Quantitative justification of the change from 10% to 30% for human epidermal growth factor receptor 2 scoring in the American Society of Clinical Oncology/College of American Pathologists guidelines: tumor heterogeneity in breast cancer and its implications for tissue microarray based assessment of outcome.
J Clin Oncol
; 25(34): 5418-25, 2007 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18048824
8.
Bimodal population or pathologist artifact?
J Clin Oncol
; 25(17): 2487-8, 2007 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-17557963
Resultados
1 -
8
de 8
1
Próxima >
>>